Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML). Although experience is too limited to permit evidence-based evaluation of survival, the available data fully justify critical reassessment of CML management. The panel therefore reviewed tr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 15, 2006
|
| In: |
Blood
Year: 2006, Jahrgang: 108, Heft: 6, Pages: 1809-1820 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2006-02-005686 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2006-02-005686
|
| Verfasserangaben: | Michele Baccarani, Giuseppe Saglio, John Goldman, Andreas Hochhaus, Bengt Simonsson, Frederick Appelbaum, Jane Apperley, Francisco Cervantes, Jorge Cortes, Michael Deininger, Alois Gratwohl, François Guilhot, Mary Horowitz, Timothy Hughes, Hagop Kantarjian, Richard Larson, Dietger Niederwieser, Richard Silver, and Rudiger Hehlmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1801373531 | ||
| 003 | DE-627 | ||
| 005 | 20220820181150.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220511s2006 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2006-02-005686 |2 doi | |
| 035 | |a (DE-627)1801373531 | ||
| 035 | |a (DE-599)KXP1801373531 | ||
| 035 | |a (OCoLC)1341459673 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Baccarani, Michele |d 1942-2021 |e VerfasserIn |0 (DE-588)1160739870 |0 (DE-627)1024168077 |0 (DE-576)176845674 |4 aut | |
| 245 | 1 | 0 | |a Evolving concepts in the management of chronic myeloid leukemia |b recommendations from an expert panel on behalf of the European LeukemiaNet |c Michele Baccarani, Giuseppe Saglio, John Goldman, Andreas Hochhaus, Bengt Simonsson, Frederick Appelbaum, Jane Apperley, Francisco Cervantes, Jorge Cortes, Michael Deininger, Alois Gratwohl, François Guilhot, Mary Horowitz, Timothy Hughes, Hagop Kantarjian, Richard Larson, Dietger Niederwieser, Richard Silver, and Rudiger Hehlmann |
| 264 | 1 | |c September 15, 2006 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.05.2022 | ||
| 520 | |a The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML). Although experience is too limited to permit evidence-based evaluation of survival, the available data fully justify critical reassessment of CML management. The panel therefore reviewed treatment of CML since 1998. It confirmed the value of IM (400 mg/day) and of conventional allogeneic hematopoietic stem cell transplantation (alloHSCT). It recommended that the preferred initial treatment for most patients newly diagnosed in chronic phase should now be 400 mg IM daily. A dose increase of IM, alloHSCT, or investigational treatments were recommended in case of failure, and could be considered in case of suboptimal response. Failure was defined at 3 months (no hematologic response [HR]), 6 months (incomplete HR or no cytogenetic response [CgR]), 12 months (less than partial CgR [Philadelphia chromosome-positive (Ph+) > 35%]), 18 months (less than complete CgR), and in case of HR or CgR loss, or appearance of highly IM-resistant BCR-ABL mutations. Suboptimal response was defined at 3 months (incomplete HR), 6 months (less than partial CgR), 12 months (less than complete CgR), 18 months (less than major molecular response [MMolR]), and, in case of MMolR loss, other mutations or other chromosomal abnormalities. The importance of regular monitoring at experienced centers was highlighted. | ||
| 700 | 1 | |a Saglio, Giuseppe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldman, John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 aut | |
| 700 | 1 | |a Simonsson, Bengt |e VerfasserIn |4 aut | |
| 700 | 1 | |a Appelbaum, Frederick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Apperley, Jane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cervantes, Francisco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cortes, Jorge |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deininger, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gratwohl, Alois |e VerfasserIn |4 aut | |
| 700 | 1 | |a Guilhot, François |e VerfasserIn |4 aut | |
| 700 | 1 | |a Horowitz, Mary |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hughes, Timothy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kantarjian, Hagop |e VerfasserIn |4 aut | |
| 700 | 1 | |a Larson, Richard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Niederwieser, Dietger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Silver, Richard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 108(2006), 6, Seite 1809-1820 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Evolving concepts in the management of chronic myeloid leukemia recommendations from an expert panel on behalf of the European LeukemiaNet |
| 773 | 1 | 8 | |g volume:108 |g year:2006 |g number:6 |g pages:1809-1820 |g extent:12 |a Evolving concepts in the management of chronic myeloid leukemia recommendations from an expert panel on behalf of the European LeukemiaNet |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood-2006-02-005686 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220511 | ||
| 993 | |a Article | ||
| 994 | |a 2006 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |e 60000PH1037003489 |e 61200PH1037003489 |k 0/60000/ |k 1/60000/61200/ |p 19 |y j | ||
| 998 | |g 1107039339 |a Hochhaus, Andreas |m 1107039339:Hochhaus, Andreas |d 60000 |d 61200 |e 60000PH1107039339 |e 61200PH1107039339 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 999 | |a KXP-PPN1801373531 |e 4131856980 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Michele Baccarani, Giuseppe Saglio, John Goldman, Andreas Hochhaus, Bengt Simonsson, Frederick Appelbaum, Jane Apperley, Francisco Cervantes, Jorge Cortes, Michael Deininger, Alois Gratwohl, François Guilhot, Mary Horowitz, Timothy Hughes, Hagop Kantarjian, Richard Larson, Dietger Niederwieser, Richard Silver, and Rudiger Hehlmann"]},"person":[{"given":"Michele","display":"Baccarani, Michele","family":"Baccarani","role":"aut"},{"role":"aut","family":"Saglio","given":"Giuseppe","display":"Saglio, Giuseppe"},{"given":"John","display":"Goldman, John","role":"aut","family":"Goldman"},{"family":"Hochhaus","role":"aut","display":"Hochhaus, Andreas","given":"Andreas"},{"role":"aut","family":"Simonsson","display":"Simonsson, Bengt","given":"Bengt"},{"given":"Frederick","display":"Appelbaum, Frederick","family":"Appelbaum","role":"aut"},{"role":"aut","family":"Apperley","given":"Jane","display":"Apperley, Jane"},{"given":"Francisco","display":"Cervantes, Francisco","role":"aut","family":"Cervantes"},{"display":"Cortes, Jorge","given":"Jorge","role":"aut","family":"Cortes"},{"display":"Deininger, Michael","given":"Michael","family":"Deininger","role":"aut"},{"family":"Gratwohl","role":"aut","given":"Alois","display":"Gratwohl, Alois"},{"given":"François","display":"Guilhot, François","family":"Guilhot","role":"aut"},{"family":"Horowitz","role":"aut","display":"Horowitz, Mary","given":"Mary"},{"given":"Timothy","display":"Hughes, Timothy","family":"Hughes","role":"aut"},{"family":"Kantarjian","role":"aut","display":"Kantarjian, Hagop","given":"Hagop"},{"given":"Richard","display":"Larson, Richard","family":"Larson","role":"aut"},{"display":"Niederwieser, Dietger","given":"Dietger","family":"Niederwieser","role":"aut"},{"given":"Richard","display":"Silver, Richard","role":"aut","family":"Silver"},{"given":"Rüdiger","display":"Hehlmann, Rüdiger","family":"Hehlmann","role":"aut"}],"recId":"1801373531","note":["Gesehen am 11.05.2022"],"title":[{"subtitle":"recommendations from an expert panel on behalf of the European LeukemiaNet","title":"Evolving concepts in the management of chronic myeloid leukemia","title_sort":"Evolving concepts in the management of chronic myeloid leukemia"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1801373531"],"doi":["10.1182/blood-2006-02-005686"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"recId":"266886647","title":[{"title":"Blood","subtitle":"journal of the American Society of Hematology","title_sort":"Blood"}],"id":{"eki":["266886647"],"issn":["1528-0020"],"zdb":["1468538-3"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946"}],"language":["eng"],"part":{"extent":"12","pages":"1809-1820","issue":"6","text":"108(2006), 6, Seite 1809-1820","volume":"108","year":"2006"},"note":["Gesehen am 21.04.2023"],"pubHistory":["1.1946 -"],"corporate":[{"role":"isb","display":"American Society of Hematology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Evolving concepts in the management of chronic myeloid leukemia recommendations from an expert panel on behalf of the European LeukemiaNetBlood","titleAlt":[{"title":"Blood online"}]}],"origin":[{"dateIssuedKey":"2006","dateIssuedDisp":"September 15, 2006"}]} | ||
| SRT | |a BACCARANIMEVOLVINGCO1520 | ||